Skip to content

Vitamin D Treatment for Crohn´s Disease

Remission Keeping and Remission Inducing Effect by Vitamin-D in Crohns Disease, and in Vitro Vitamin-D Mediated T-Cell Immunomodulation

Status
UNKNOWN
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00132184
Enrollment
110
Registered
2005-08-19
Start date
2005-09-30
Completion date
2008-02-29
Last updated
2007-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohns Disease

Keywords

Vitamin D, Crohns Disease

Brief summary

The purpose of this study is to examine whether vitamin D treatment is effective in Crohn's disease.

Detailed description

Crohns Disease is an inflammatory disease of primarily the small intestine and colon. In recent years scientists have hypothesized that low blood vitamin-D levels play a role in the development of autoimmune diseases, including Crohns disease. The purpose of this study is to examine whether vitamin-D is effective in keeping remission in inactive Crohns Disease (double blind placebo controlled trial). The patients who have active disease in the placebo group (reach primary endpoint), will in an open setting receive a higher single dose vitamin-D and the effect will be measured within 4 weeks.

Interventions

DRUGVitamin D

Sponsors

University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Crohn's disease * Inactive Crohn's disease for at least 4 weeks * Crohn's Disease Activity Index (CDAI) \< 150 * C-reactive protein within normal range * Serum albumin within normal range

Exclusion criteria

* Hypercalcemia * Short bowel syndrome * Pregnancy

Design outcomes

Primary

MeasureTime frame
Relapse rate within 1 year treatment; CDAI>220

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026